课题基金 / 基金详情

Adoptive transfers of in vitro differentiated plasmacytoid dendritic cells to prevent acute lymphoblastic leukemia relapse: mechanisms and biomarkers of sensitivity

Adoptive transfers of in vitro differentiated plasmacytoid dendritic cells to prevent acute lymphoblastic leukemia relapse: mechanisms and biomarkers of sensitivity
体外分化浆细胞样树突状细胞的过继转移预防急性淋巴细胞白血病复发:机制和敏感性生物标志物
批准号:
402466
负责人:
Duval Michel
金额:
$49.04万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-03-01 至 2023-03-01

项目摘要

项目成果

Duval Michel的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Acute leukemia is the leading cause of death by cancer in children. Despite recent therapeutic advances, about 40% of children with acute lymphoblastic leukemia refractory to chemotherapy still die from their disease. The only hope of cure for these child
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phase I first-in-human trial for ThINKK adoptive immunotherapy in children with high-risk cancers
Phase I first-in-human trial of ThINKK adoptive immunotherapy in children with high-risk cancers
Toward the cure of neuroblastoma: innovative immunotherapeutic approaches
Preclinical models of natural killer cell-based immunotherapy to cure refractory childhood acute lymphoblastic leukemia
海外基金